Publication

  1. Shah CP, Heier JS. YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.  JAMA Ophthalmol. 2017 Sep 1;135(9):918-923. doi: 10.1001/jamaophthalmol.2017.2388.
  2. Kokavec J, Wu Z, Sherwin JC, Ang AJ, Ang GS. Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters. Cochrane Database Syst Rev. 2017 Jun 1;6:CD011676. doi: 10.1002/14651858.CD011676.pub2
  3. Delaney YM, Oyinloye A, Benjamin L. Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters. Eye (Lond). 2002 Jan;16(1):21-6.
  4. Vandorselaer T, Van De Velde F, Tassignon MJ. Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters. Bull Soc Belge Ophtalmol. 2001;(280):15-9.
  5. Vogel A, Hentschel W, Holzfuss J, Lauterborn W. Cavitation bubble dynamics and acoustic transient generation in ocular surgery with pulsed neodymium: YAG lasers.  Ophthalmology. 1986 Oct;93(10):1259-69.
  6. Lim JI. YAG Laser Vitreolysis-Is It as Clear as It Seems? JAMA Ophthalmol. 2017Sep1;135(9):924-925. 
  7. Milston R Madigan MC, Sebag J. Vitreous floaters: Etiology, diagnostics, and management. Surv Ophthalmol. 2016 Mar-Apr;61(2):211-27. doi: 10.1016/j.survophthal.2015.11.008. Epub 2015 Dec 8
  8. Kasimov ÉM, Alieva NI, Mamedzade AN. Results of YAG-laser vitreolysis in proliferative diabetic retinopathy complicated by vitreous hemorrhage (Article in Russian).  Vestn Oftalmol. 2014 Jul-Aug;130(4):22-6.
  9. Gao YB. Vitreolysis with Nd:YAG laser (Article in Chinese). Zhonghua Yan Ke Za Zhi. 1990 Nov;26(6):352-4.
  10. Fankhauser F, Kwasniewska S. Laser Vitreolysis. A review. Ophthalmologica. 2002 Mar-Apr;216(2):73-84
  11. Levy JH, Pisacano AM. Clinical experience with Nd:YAG laser vitreolysis in the anterior segment. J Cataract Refract Surg. 1987 Sep;13(5):548-50.
  12. Hosseini H, Mehryar M, Farvardin M. Triamcinolone-assisted neodymium:YAG laser vitreolysis. Ophthalmic Surg Lasers Imaging. 2008 May-Jun;39(3):234-6.
  13. Little HL, Jack RL. Q-switched neodymium: YAG laser surgery of the vitreous. Graefes Arch Clin Exp Ophthalmol. 1986;224(3):240-6.
  14. Fankhauser F, Kwasniewska S, van der Zypen E. Vitreolysis with the Q-switched laser. Arch Ophthalmol. 1985 Aug;103(8):1166-71
  15. Tchah H, Rosenberg M, Larson RS, Lindstrom RL. Neodymium: YAG laser vitreolysis for treatment and prophylaxis of cystoid macular oedema. Aust N Z J Ophthalmol. 1989 May;17(2):179-83.
  16. Tassignon MJ, Ní Dhubhghaill S, Ruiz Hidalgo I, Rozema JJ. Subjective Grading of Subclinical Vitreous Floaters. Asia Pac J Ophthalmol (Phila). 2016 Mar-Apr;5(2):104-9. 
  17. Mamou J, Wa CA, Yee KM, Silverman RH, Ketterling JA, Sadun AA, Sebag J. Ultrasound-based quantification of vitreous floaters correlates with contrast sensitivity and quality of life. Invest Ophthalmol Vis Sci. 2015 Jan 22;56(3):1611-7. doi: 10.1167/iovs.14-15414.
  18. Garcia GA , Khoshnevis M, Yee KMP, Nguyen-Cuu J, Nguyen JH, Sebag J. Degradation of Contrast Sensitivity Function Following Posterior Vitreous Detachment. Am J Ophthalmol. 2016 Dec;172:7-12. doi: 10.1016/j.ajo.2016.09.005. Epub 2016 Sep 12.
  19. Garcia GA, Khoshnevis M, Yee KMP, Nguyen JH, Nguyen-Cuu J, Sadun AA, Sebag JThe effects of aging vitreous on contrast sensitivity function. Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):919-925. doi: 10.1007/s00417-018-3957-1. Epub 2018 Mar 13.
  20. Webb BF, Webb JR, Schroeder MC, North CS. Prevalence of vitreous floaters in a community sample of smartphone users. Int J Ophthalmol. 2013 Jun 18;6(3):402-5. doi: 10.3980/j.issn.2222-3959.2013.03.27. Print 2013.
  21. Singh IP. Novel OCT Application and Optimized YAG Laser Enable Visualization and Treatment of Mid- to Posterior Vitreous Floaters. Ophthalmic Surg Lasers Imaging Retina. 2018 Oct 01;49(10):806-811
  22. Brasse K, Schmitz-Valckenberg S, Jünemann A, Roider J, Hoerauf H. YAG laser vitreolysis for treatment of symptomatic vitreous opacities . Ophthalmologe. 2019 Jan;116(1):73-84.
  23. Bergstrom R, Czyz CN. Vitreous Floaters. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jun 10ƒƒ
  24. Cohen MN, Rahimy E, Ho AC, Garg SJ. Management of Symptomatic Floaters: Current Attitudes, Beliefs, and Practices Among Vitreoretinal Surgeons. Ophthalmic Surg Lasers Imaging Retina. 2015 Sep;46(8):859-65. doi: 10.3928/23258160-20150909-11.
  25. Nguyen JH, Nguyen-Cuu J, Yu F, Yee KM, Mamou J, Silverman RH, Ketterling J, Sebag J. Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis. Ophthalmology. 2019 Jun 22. pii: S0161-6420(18)32553-3. doi: 10.1016/j.ophtha.2019.06.021.
  26. Sebag J, Sadun AA. Re: Thompson: Much Ado about Nothing (or Something)-What Is the Role of Vitrectomy and Yttrium-Aluminum-Garnet Laser for Vitreous Floaters? Ophthalmol Retina. 2019 Jul;3(7):e6. doi: 10.1016/j.oret.2019.01.025. Epub 2019 Apr 3.
  27. Sebag J, Yee KM, Wa CA, Huang LC, Sadun AA.Vitrectomy for floaters: prospective efficacy analyses and retrospective safety profile. Retina. 2014 Jun;34(6):1062-8. doi: 10.1097/IAE.0000000000000065.
  28. Sebag J Vitreous: Not just through it. Clin Exp Ophthalmol. 2016 Sep;44(7):547-549. doi: 10.1111/ceo.12823.
  29. Rostami B, Nguyen-Cuu J, Brown G, Brown M, Sadun AA, Sebag J. Cost-Effectiveness of Limited Vitrectomy for Vision-Degrading Myodesopsia. Am J Ophthalmol. 2019 Aug;204:1-6. doi: 10.1016/j.ajo.2019.02.032. Epub 2019 Mar 6.
  30. Wa C, Sebag J. Safety of vitrectomy for floaters. Am J Ophthalmol. 2011 Dec;152(6):1077; author reply 1077-8. doi: 10.1016/j.ajo.2011.09.003.
  31. Sebag J. Floaters and the quality of life. Am J Ophthalmol. 2011 Jul;152(1):3-4.e1. doi: 10.1016/j.ajo.2011.02.015.
  32. Sebag J. To see the invisible: the quest of imaging vitreous. Dev Ophthalmol. 2008;42:5-28. doi: 10.1159/000138754.
  33. Sauvage F, Fraire JC, Remaut K, Sebag J, Peynshaert K, Harrington M, Van de Velde FJ, Xiong R, Tassignon MJ, Brans T, Braeckmans K, De Smedt SC  Photoablation of Human Vitreous Opacities by Light-Induced Vapor Nanobubbles. ACS Nano. 2019 Jul 23;13(7):8401-8416. doi: 10.1021/acsnano.9b04050. Epub 2019 Jul 12
  34. Vandorselaer T1, Van De Velde F, Tassignon MJ. Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters. Bull Soc Belge Ophtalmol. 2001;(280):15-9.
  35. Van der Veken A, Van de velde F, Smeets B, Tassignon MJ. Nd:YAG laser posterior hyaloidotomy for the treatment of a premacular vitreous floater. Bull Soc Belge Ophtalmol. 1997;265:39-43.
  36. Tassignon MJ, Kreissig I, Stempels N, Brihaye M. Indications for Q-switched and mode-locked Nd: YAG lasers in vitreoretinal pathology. Eur J Ophthalmol. 1991 Jul-Sep;1(3):123-30.
  37. van Overdam KA, van Etten PG, van Meurs JC, Manning SS. Vitreous Wiping, a new technique for removal of vitreous cortex remnants during vitrectomy. Acta Ophthalmol. 2019 Aug;97(5):e747-e752. doi: 10.1111/aos.13991. Epub 2018 Dec 7.
  38. Wu RH, Zhang R, Lin Z, Liang QH, Moonasar N. A comparison between topical and retrobulbar anesthesia in 27-gauge vitrectomy for vitreousfloaters: a randomized controlled trial. BMC Ophthalmol. 2018 Jul 7;18(1):164. doi: 10.1186/s12886-018-0838-7.
  39. Lin Z, Moonasar N, Wu RH, Seemongal-Dass RR. 27-Gauge Vitrectomy for Symptomatic Vitreous Floaters with Topical Anesthesia. Case Rep Ophthalmol. 2017 Jan 20;8(1):35-39. doi: 10.1159/000453332. eCollection 2017 Jan-Apr.
  40. Sun X, Tian J, Wang J, Zhang J, Wang Y, Yuan G Nd:YAG Laser Vitreolysis for Symptomatic Vitreous Floaters: Application of Infrared Fundus Photography in Assessing the Treatment Efficacy. J Ophthalmol. 2019 Jan 27;2019:8956952. doi: 10.1155/2019/8956952. eCollection 2019.
  41. Schiff WM1, Chang S, Mandava N, Barile GR. Pars plana vitrectomy for persistent, visually significant vitreous opacities. Retina. 2000;20(6):591-6.
  42. ChiTing Horng, FuAn Chen, DaihHuang Kuo, LiChai Chen, ShouShan Yeh, and PoChuen Shieh. Pharmacologic vitreolysis of vitreous floaters by 3-month pineapple supplement in Taiwan: A pilot study. J Am Sci 2019;15(4):1730
  43. Luo J, An X, Kuang Y. Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters. J Int Med Res. 2018 Nov;46(11):4465-4471. doi: 10.1177/0300060518794245. Epub 2018 Sep 10.
  44. 44.Sommerville DN. Vitrectomy for vitreous floaters: analysis of the benefits and risks. Curr Opin Ophthalmol. 2015 May;26(3):173-6.
  45. Patel SB, Snyder ME, Riemann CD, Osher JM, Mi CW, Sisk RA. Combined phacoemulsification surgery with multifocal intraocular lens implantation and pars plana vitrectomy for symptomatic vitreous opacities. Retin Cases Brief Rep. 2019 Apr 8, doi: 10.1097/ICB.0000000000000873.
  46. Shaimova VA, Shaimov TB, Shaimov RB, Galin AY, Goloshchapova ZA, Ryzhkov PK, Fomin AV Evaluation of YAG-laser vitreolysis effectiveness based on quantitative characterization of vitreous floaters (article in Russian) Vestn Oftalmol. 2018;134(1):56-62. doi: 10.17116/oftalma2018134156-62.
  47. Sun IT, Lee TH, Chen CH Rapid Cataract Progression after Nd:YAG Vitreolysis for Vitreous Floaters: A Case Report and Literature Review. Case Rep Ophthalmol. 2017 May 29;8(2):321-325. doi: 10.1159/000477159. eCollection 2017 May-Aug.
  48. Danzig C, Hariprasad SM. Surgical management of symptomatic vitreous floaters. Ophthalmic Surg Lasers Imaging Retina. 2014 Nov-Dec;45(6):1-3. doi: 10.3928/23258160-20141118-01.
  49. Hurst J, Johnson D, Law C, Schweitzer K, Sharma S. Value of subjective visual reduction in patients with acute-onset floaters and/or flashes. Can J Ophthalmol. 2015 Aug;50(4):265-8. doi: 10.1016/j.jcjo.2015.06.001.